Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Corbus Pharmaceuticals Inc.

Clinical trials sponsored by Corbus Pharmaceuticals Inc., explained in plain language.

Corbus Pharmaceuticals Inc. CRBP NASDAQ

Develops treatments for inflammatory and fibrotic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New cancer drug CRB-701 targets Nectin-4 in advanced tumors

Disease control Recruiting now

This study tests a drug called CRB-701, which is designed to find and attack cancer cells that have a protein called Nectin-4 on their surface. The trial includes 348 adults with advanced solid tumors that have not responded to standard treatments. Researchers aim to find a safe …

Phase: PHASE1, PHASE2 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC